AVNS
Avanos Medical Inc.
$11.91
-$0.37(-3.01%)
46
Overall
--
Value
45
Tech
47
Quality
Market Cap
$552.65M
Volume
1.31M
52W Range
$9.30 - $24.39
Target Price
$14.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $1.6B | $566.2M | $611.6M | $652.3M | $697.6M | $714.8M | $744.6M | $684.1M | $673.3M | $687.8M | ||
| Total Revenue | $1.6B | $566.2M | $611.6M | $652.3M | $697.6M | $714.8M | $744.6M | $684.1M | $673.3M | $687.8M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-1.0B | $-269.0M | $-274.7M | $-261.4M | $295.4M | $341.5M | $287.8M | $289.9M | $293.6M | $306.5M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $531.6M | $297.2M | $336.9M | $390.9M | $402.2M | $373.3M | $299.2M | $394.2M | $379.7M | $381.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $435.3M | $404.3M | $380.0M | $390.4M | $457.9M | $419.4M | $355.4M | $358.7M | $375.5M | $340.8M | ||
| Research & Development | $32.3M | $38.4M | $38.2M | $41.8M | $37.7M | $34.9M | $32.3M | $29.2M | $27.2M | $26.2M | ||
| Research Expense | $32.3M | $38.4M | $38.2M | $41.8M | $37.7M | $34.9M | $32.3M | $29.2M | $27.2M | $26.2M | ||
| Selling, General & Administrative | $398.5M | $346.2M | $321.7M | $340.4M | $399.1M | $332.6M | $300.3M | $326.5M | $335.0M | $318.5M | ||
| Selling & Marketing Expenses | $398.5M | $346.2M | $321.7M | $340.4M | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-22.0M | $-22.0M | $-23.9M | $-19.6M | $399.1M | $332.6M | $300.3M | $326.5M | $335.0M | $318.5M | ||
| Promotion & Advertising | -- | -- | -- | $-2.3M | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-14.0M | $-15.0M | $-12.6M | $-10.5M | $500.0K | $700.0K | $800.0K | -- | -- | -- | ||
| Depreciation & Amortization | $-65.4M | $-65.2M | $-18.8M | $-13.5M | $16.9M | $23.5M | $21.6M | $17.5M | $19.2M | $20.3M | ||
| Depreciation & Amortization | $-65.4M | $-65.2M | $-18.8M | $-13.5M | $16.9M | $23.5M | $21.6M | -- | -- | -- | ||
| Amortization | $-26.0M | $-21.0M | $-20.7M | $-20.0M | $800.9M | $802.5M | $801.6M | $760.3M | $796.1M | $455.6M | ||
| Other Operating Expenses | $4.5M | $19.7M | $20.1M | $8.2M | $21.1M | $51.9M | $22.8M | $3.0M | $13.3M | $-3.9M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $96.3M | $-107.1M | $-43.1M | $500.0K | $-55.7M | $-46.1M | $10.4M | $35.5M | $4.2M | $-396.2M | ||
| EBITDA | $-312.0M | $-41.3M | $18.9M | $41.8M | $-12.1M | $-2.0M | $-500.0K | $84.4M | $53.2M | $-345.6M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $33.1M | $32.7M | $31.6M | $26.4M | $15.0M | $15.6M | $3.3M | $10.0M | $15.0M | $12.2M | ||
| Intinc | $300.0K | $600.0K | $2.5M | $7.8M | $6.7M | $1.2M | $200.0K | $1.2M | $2.9M | $5.1M | ||
| Net Non-Operating Interest Income/Expense | $-32.8M | $-32.1M | $-29.1M | $-18.6M | $-8.3M | $-14.4M | $-3.1M | $-8.8M | $-12.1M | $-7.1M | ||
| Other Income/Expense | $-1.6B | $-1.6B | -- | $-716.4M | $-734.1M | $9.6M | $1.8M | $7.8M | -- | $-6.9M | ||
| Other Special Charges | $-1.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-70.4M | $-29.1M | $-43.2M | $-54.7M | $29.2M | $30.3M | $22.6M | -- | -- | -- | ||
| Special Income Charges | $-474.0M | $29.1M | $43.2M | $54.7M | $-29.2M | $-30.3M | $-22.6M | -- | $-28.2M | $-436.7M | ||
| Impairment of Capital Assets | $474.0M | -- | -- | -- | -- | -- | -- | -- | -- | $436.7M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-377.4M | $-106.5M | $-40.6M | $8.3M | $-49.0M | $-44.9M | $-38.8M | $36.7M | $7.1M | $-391.1M | ||
| Pre-Tax Income | $-410.5M | $-139.2M | $-72.2M | $-18.1M | $-64.0M | $-60.5M | $7.3M | $26.7M | $-7.9M | $-403.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $15.8M | $-55.9M | $-40.1M | $-9.6M | $-18.1M | $-33.3M | $-11.2M | $5.2M | $2.0M | $-17.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $-426.3M | $-83.3M | $-32.1M | $-8.5M | $-45.9M | $-27.2M | $6.3M | $50.5M | $-61.8M | $-392.1M | ||
| Net Income (Continuing Operations) | $-426.3M | $-83.3M | $-32.1M | $-8.5M | $-45.9M | $-27.2M | $6.3M | $21.5M | $-9.9M | $-386.3M | ||
| Net Income (Discontinued Operations) | $-426.3M | $-83.3M | $-32.1M | $-8.5M | $-45.9M | $-27.2M | $6.3M | $50.5M | $-61.8M | $-392.1M | ||
| Net Income (Common Stockholders) | $-426.3M | $-83.3M | $-32.1M | $-8.5M | $-45.9M | $-27.2M | $6.3M | $50.5M | $-61.8M | $-392.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-607.5M | $135.3M | $105.3M | $129.0M | $753.3M | $760.9M | $734.2M | $648.6M | $669.1M | $647.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $46.6M | $46.6M | $46.8M | $47.2M | $47.6M | $47.8M | $47.3M | $46.8M | $46.8M | $46.0M | ||
| Average Shares Outstanding (Diluted) | $46.6M | $46.6M | $46.8M | $47.2M | $47.6M | $47.8M | $47.3M | $47.2M | $46.8M | $46.0M | ||
| Shares Outstanding | $46.6M | $46.7M | $46.9M | $47.5M | $47.8M | $48.0M | $47.3M | $46.6M | $46.2M | $46.0M | ||
| Basic EPS | $-9.15 | $0.85 | $1.69 | $1.22 | $-0.96 | $-0.57 | $0.11 | $1.08 | $-1.32 | $-8.53 | ||
| Basic EPS (Continuing Operations) | -- | $-1.79 | $-0.69 | $-0.18 | $-0.96 | $-0.57 | $0.11 | $1.08 | $-0.21 | $-8.4 | ||
| Diluted EPS | $-9.15 | $0.85 | $1.69 | $1.22 | $-0.96 | $-0.57 | $0.11 | $1.07 | $-1.32 | $-8.53 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.79 | $-0.69 | $-0.18 | $-0.96 | $-0.57 | $0.11 | $1.07 | $-0.21 | $-8.4 | ||
| OTHER METRICS | ||||||||||||
| Basic Discontinuous Operations | -- | $2.64 | $2.38 | $1.4 | -- | -- | -- | -- | $-1.11 | $-0.13 | ||
| Diluted Discontinuous Operations | -- | $2.64 | $2.38 | $1.4 | -- | -- | -- | -- | $-1.11 | $-0.13 | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | $6.0M | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | $123.1M | $111.4M | $98.4M | -- | -- | -- | $29.0M | $-51.9M | $-5.8M | ||
| Other Gand A | $-22.0M | $-22.0M | $-23.9M | $-19.6M | $399.1M | $332.6M | $300.3M | $326.5M | $335.0M | $318.5M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $9.6M | $7.8M | -- | -- | -- | ||
| Rent And Landing Fees | $-22.0M | $-22.0M | $-23.9M | $-19.6M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $398.5M | $346.2M | $321.7M | $340.4M | -- | -- | -- | -- | -- | -- | ||
| Restruct | $-70.4M | $-29.1M | $-43.2M | $-54.7M | $29.2M | $30.3M | $22.6M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVNS | $11.91 | -3.0% | 1.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |